These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 32585775

  • 41. Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.
    Inamoto T, Matsuyama H, Ibuki N, Komura K, Takahara K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Tatsumi Y, Yasumoto H, Azuma H, Nishinihon Uro-Oncology Collaborative Group.
    J Urol; 2018 Apr; 199(4):933-939. PubMed ID: 29037861
    [Abstract] [Full Text] [Related]

  • 42. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
    Pelcovits A, Mueller-Leonhard C, Mega A, Amin A, Kim SP, Golijanin D, Gershman B.
    World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 45. Overexpression of EIF5A2 in upper urinary tract urothelial carcinoma is a new independent prognostic marker of survival.
    Fang Y, Cen JJ, Cao JZ, Huang Y, Feng ZH, Lu J, Wei JH, Chen ZH, Liang YP, Liao B, Luo JH, Chen W.
    Future Oncol; 2019 Jun; 15(17):2009-2018. PubMed ID: 30931608
    [Abstract] [Full Text] [Related]

  • 46. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma.
    Raza SJ, Miller C, May A, Davaro F, Siddiqui SA, Hamilton Z.
    Can J Urol; 2019 Aug; 26(4):9852-9858. PubMed ID: 31469641
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [Abstract] [Full Text] [Related]

  • 49. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y, Grande P, Seisen T, Gobert A, Gomez FD, Cussenot O, Roupret M.
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis.
    Nazzani S, Bazinet A, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Saad F, Zorn KC, Montanari E, Briganti A, Carmignani L, Karakiewicz PI.
    Int J Urol; 2019 Apr; 26(4):487-492. PubMed ID: 30756440
    [Abstract] [Full Text] [Related]

  • 55. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
    Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A, Kapoor A, Black P, Lacombe L, Tanguay S, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Izawa JI.
    Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
    Zhai TS, Jin L, Zhou Z, Liu X, Liu H, Chen W, Lu JY, Yao XD, Feng LM, Ye L.
    BMC Cancer; 2019 Dec 12; 19(1):1207. PubMed ID: 31830927
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
    Otsuka M, Kamasako T, Uemura T, Takeshita N, Shinozaki T, Kobayashi M, Komaru A, Fukasawa S.
    Int J Urol; 2018 Oct 12; 25(10):871-878. PubMed ID: 30103271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.